Rinvoq ER 15 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FCZ9Y
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,187
Award facts
- Contract value 100% obligated
- $31,187.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $31,187.01 to AmerSourceBergen Drug Corp for the supply of RINVOQ ER 15 mg tablets (30-count units) with a completion date of January 16, 2026. This non-competitive, firm fixed-price delivery order was issued on January 15, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerSourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving federal healthcare systems and is well-positioned to fulfill this requirement as a critical vendor within the Department of Defense medical supply chain.
This delivery order operates under AmerSourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical commodities to military healthcare programs globally. RINVOQ (upadacitinib), a JAK inhibitor used primarily for rheumatoid arthritis and other inflammatory conditions, reflects the specialized pharmaceutical products within the company's federal contract portfolio supporting military treatment facilities and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FCZ9Y?
SPE2DR26FCZ9Y was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26FCZ9Y worth?
The government has obligated $31,187 on SPE2DR26FCZ9Y.
Is contract SPE2DR26FCZ9Y an order under another contract?
Yes. SPE2DR26FCZ9Y is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCZ9Y competed?
The extent of competition for SPE2DR26FCZ9Y was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award